• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低血管性血友病因子:有时是风险因素,有时是疾病。

Low von Willebrand factor: sometimes a risk factor and sometimes a disease.

机构信息

Departments of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.

出版信息

Hematology Am Soc Hematol Educ Program. 2009:106-12. doi: 10.1182/asheducation-2009.1.106.

DOI:10.1182/asheducation-2009.1.106
PMID:20008188
Abstract

A sufficiently low level of von Willebrand factor (VWF) predisposes to bleeding that can be quite serious, and low VWF is a diagnostic feature of von Willebrand disease (VWD) type 1, which is characterized by partial quantitative deficiency of VWF. Recent groundbreaking studies of patients with VWD type 1 have delineated several pathophysiologic mechanisms that determine the plasma concentration of VWF, but the relationship between VWF level and the likelihood of bleeding remains less well understood. In part, this problem reflects the broad range of VWF levels in the population, so that the distinction between "normal" and "low" is arbitrary. The risk of bleeding certainly increases as the VWF level decreases, but the relationship is not very strong until the VWF level is very low. Furthermore, mild bleeding symptoms are common in apparently healthy populations and have many causes other than defects in VWF, which can make it impossible to attribute bleeding to any single factor, such as low VWF. These difficulties might be resolved by an epidemiologic approach to VWF and other risk factors for bleeding, analogous to how physicians manage multiple risk factors for cardiovascular disease or venous thromboembolism.

摘要

血管性血友病因子(VWF)水平过低可导致严重出血,这是血管性血友病(VWD)1 型的一个诊断特征,其特点是 VWF 部分数量缺乏。最近对 VWD 1 型患者的突破性研究描绘了几个决定 VWF 血浆浓度的病理生理机制,但 VWF 水平与出血可能性之间的关系仍不太清楚。部分原因是人群中 VWF 水平范围较广,因此“正常”和“低”之间的区分是任意的。VWF 水平越低,出血的风险肯定越大,但直到 VWF 水平非常低,这种关系才不是很强。此外,轻度出血症状在看似健康的人群中很常见,其原因有很多,不仅仅是 VWF 缺陷,这使得将出血归因于任何单一因素(如 VWF 水平低)变得不可能。通过对 VWF 及其他出血风险因素进行流行病学研究,可以解决这些困难,类似于医生如何管理心血管疾病或静脉血栓栓塞的多种风险因素。

相似文献

1
Low von Willebrand factor: sometimes a risk factor and sometimes a disease.低血管性血友病因子:有时是风险因素,有时是疾病。
Hematology Am Soc Hematol Educ Program. 2009:106-12. doi: 10.1182/asheducation-2009.1.106.
2
Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.1型/2E型(2A亚型IIE)血管性血友病、1型维琴察型血管性血友病以及由血管性血友病因子基因的D3、D4、B1 - B3和C1 - C2结构域突变引起的轻型1型血管性血友病的实验室诊断。血管性血友病因子多聚体及血管性血友病因子前肽/抗原比值的作用。
Acta Haematol. 2009;121(2-3):128-38. doi: 10.1159/000214853. Epub 2009 Jun 8.
3
Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearance.1 型血管性血友病患者出血倾向和抗出血治疗效果与血管性血友病因子清除率增加。
Thromb Haemost. 2011 Apr;105(4):647-54. doi: 10.1160/TH10-11-0697. Epub 2011 Jan 25.
4
CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease.CLEC4M 和 STXBP5 基因突变可导致血管性血友病患者 von Willebrand 因子水平的变化。
J Thromb Haemost. 2015 Jun;13(6):956-66. doi: 10.1111/jth.12927. Epub 2015 May 9.
5
Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease.血管性血友病中血小板血管性血友病因子检测的诊断价值
PLoS One. 2016 Aug 17;11(8):e0161310. doi: 10.1371/journal.pone.0161310. eCollection 2016.
6
Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.隐性严重1型和3型血管性血友病(VWD)、无症状杂合子携带者与血型O相关的血管性血友病因子缺乏症以及显性1型VWD的特征分析
Clin Appl Thromb Hemost. 2006 Jul;12(3):277-95. doi: 10.1177/1076029606291401.
7
Similarity in joint and mucous bleeding syndromes in type 2N von Willebrand disease and severe hemophilia A coexisting with type 1 von Willebrand disease in two Chinese pedigrees.两个中国家系中2N型血管性血友病与严重A型血友病合并1型血管性血友病时关节和黏膜出血综合征的相似性
Blood Cells Mol Dis. 2014 Apr;52(4):181-5. doi: 10.1016/j.bcmd.2013.11.005. Epub 2013 Dec 16.
8
Laboratory diagnostic approach of the parents-children relationship in differentiating low-level von Willebrand factor from mild type 1 von Willebrand disease.区分低水平血管性血友病因子与轻型1型血管性血友病疾病时亲子关系的实验室诊断方法
Blood Coagul Fibrinolysis. 2012 Jun;23(4):351-3. doi: 10.1097/MBC.0b013e32835274f1.
9
Controversies in the diagnosis of Type 1 von Willebrand disease.1型血管性血友病诊断中的争议
Int J Lab Hematol. 2017 May;39 Suppl 1:61-68. doi: 10.1111/ijlh.12653.
10
VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease.血管性血友病因子前肽及其与血管性血友病因子、VIII 因子比值在 1 型血管性血友病诊断中的作用。
Blood. 2013 Mar 21;121(12):2336-9. doi: 10.1182/blood-2012-09-455089. Epub 2013 Jan 24.

引用本文的文献

1
A fully humanized von Willebrand disease type 1 mouse model as unique platform to investigate novel therapeutic options.一种完全人源化的1型血管性血友病小鼠模型,作为研究新型治疗方案的独特平台。
Haematologica. 2025 Apr 1;110(4):923-937. doi: 10.3324/haematol.2024.286076. Epub 2024 Nov 28.
2
Low von Willebrand factor-unraveling an enigma wrapped in a conundrum.低 von Willebrand 因子——解开谜团。
J Thromb Haemost. 2024 Dec;22(12):3383-3388. doi: 10.1016/j.jtha.2024.08.015. Epub 2024 Sep 10.
3
Predictors of bleeding complications during catHeter-dirEcted thrombolysis for peripheral arterial occlusions (POCHET).
经皮导管溶栓治疗外周动脉闭塞(POCHET)过程中出血并发症的预测因素。
PLoS One. 2024 May 9;19(5):e0302830. doi: 10.1371/journal.pone.0302830. eCollection 2024.
4
Clusterin knockdown has effects on intracellular and secreted von Willebrand factor in human umbilical vein endothelial cells.簇集蛋白敲低对人脐静脉内皮细胞的细胞内和分泌型血管性血友病因子的影响。
PLoS One. 2024 Feb 16;19(2):e0298133. doi: 10.1371/journal.pone.0298133. eCollection 2024.
5
What can historical literature on von Willebrand disease teach us?关于血管性血友病的历史文献能教给我们什么?
Res Pract Thromb Haemost. 2023 Oct 30;7(8):102244. doi: 10.1016/j.rpth.2023.102244. eCollection 2023 Nov.
6
Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studies.再次探讨 1 型血管性血友病的分类:来自 LoVIC 和 WiN 研究联合分析的新见解。
Blood. 2024 Apr 4;143(14):1414-1424. doi: 10.1182/blood.2023022457.
7
Interaction of von Willebrand factor with blood cells in flow models: a systematic review.血流模型中血管性血友病因子与血细胞的相互作用:系统评价。
Blood Adv. 2022 Jul 12;6(13):3979-3990. doi: 10.1182/bloodadvances.2021006405.
8
Serum 25-hydroxyvitamin D and C-reactive protein and plasma von Willebrand concentrations in 23 dogs with chronic hepatopathies.23 例慢性肝病犬血清 25-羟维生素 D 和 C 反应蛋白及血浆血管性血友病因子浓度。
J Vet Intern Med. 2022 May;36(3):966-975. doi: 10.1111/jvim.16424. Epub 2022 Apr 14.
9
Multimer Analysis of Von Willebrand Factor in Von Willebrand Disease with a Hydrasys Semi-Automatic Analyzer-Single-Center Experience.使用Hydrasys半自动分析仪对血管性血友病因子进行多聚体分析——单中心经验
Diagnostics (Basel). 2021 Nov 20;11(11):2153. doi: 10.3390/diagnostics11112153.
10
Whole-exome analysis of adolescents with low VWF and heavy menstrual bleeding identifies novel genetic associations.对低 VWF 和月经过多青少年进行全外显子组分析鉴定出新的遗传关联。
Blood Adv. 2022 Jan 25;6(2):420-428. doi: 10.1182/bloodadvances.2021005118.